Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
525.00    15.00 (2.94%)
Bid:
523.00
Ask:
527.00
Spread: 4.00 (0.765%)
Market Cap: £302.10m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

AGM Trading Statement

20 May 2026 07:00

RNS Number : 9774E
Mortgage Advice Bureau (Hldgs) PLC
20 May 2026
 

20 May 2026

Mortgage Advice Bureau (Holdings) plc

("MAB" or the "Company")

 

AGM Trading Statement

 

Mortgage Advice Bureau (Holdings) plc (LSE: MAB1), a leading technology-driven UK property finance service, will hold its Annual General Meeting at 12:30pm today during which Michael Jones, Chair, will make the following statement:

"On 27 April 2026, alongside publication of its prospectus, the Company reported that it had entered 2026 with good momentum, with mortgage applications in the first 16 weeks of 2026 19% higher year-on-year.

This positive momentum has continued, with mortgage applications in the first 19 weeks of 2026 15% higher year-on-year, in line with the Board's expectations. During March and April, a period of heightened macroeconomic and interest rate uncertainty led to four weeks of accelerated refinancing activity, as customers moved to fix rates early ahead of their product expiry dates. Application levels have since normalised, with refinancing activity expected to remain robust through the remainder of 2026.

The Company's customer acquisition and retention strategies are supporting continued growth in lead flow, underpinning MAB's long track record of year-on-year revenue growth across all market conditions."

 

Enquiries:

Investor Relations investor.relations@mab.org.uk

Camarco mab@camarco.co.uk

 

About MAB:

MAB is a leading UK property finance platform that connects customers, advisers, lenders, and insurers throughout the homeownership journey. Through its scalable, technology-driven intermediary model, MAB delivers personalised mortgage and protection advice via its proprietary platform, supported by deep customer insight and a data-rich, digitally enabled framework.

Through its partner firms, known as Appointed Representatives (ARs), MAB has over 2,100 advisers providing expert advice across mortgages, specialist lending, protection and general insurance products. MAB supports its AR firms with proprietary technology and services, including adviser recruitment and lead generation, learning and development, compliance auditing and supervision, and digital marketing and website solutions.

For more information, visit www.mortgageadvicebureau.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAUKANRNBUVAAR
Date   Source Headline
20th Nov 20202:03 pmRNSHolding(s) in Company
19th Nov 20205:10 pmRNSHolding(s) in Company
19th Nov 20207:00 amRNSDividend Declaration
16th Nov 202012:54 pmRNSDirector/PDMR Shareholding
30th Oct 202012:29 pmRNSDirector/PDMR Shareholding
30th Oct 202011:00 amRNSTotal Voting Rights
14th Oct 20205:01 pmRNSDirector/PDMR Shareholding
12th Oct 20204:15 pmRNSHolding(s) in Company
9th Oct 202012:55 pmRNSIssue of Equity and PDMR dealing
30th Sep 20201:30 pmRNSTotal Voting Rights
30th Sep 202011:29 amRNSDirector/PDMR Shareholding
29th Sep 20207:00 amRNSMAB Australia: new joint venture partner
29th Sep 20207:00 amRNSInterim Results
17th Sep 202010:21 amRNSDirector/PDMR Shareholding
15th Sep 20207:00 amRNSLaunch of Mortgage Advice Bureau Later Life
28th Aug 202012:11 pmRNSDirector/PDMR Shareholding
14th Aug 20202:39 pmRNSDirector/PDMR Shareholding
31st Jul 20201:38 pmRNSDirector/PDMR Shareholding
31st Jul 20201:00 pmRNSTotal Voting Rights
30th Jul 202010:39 amRNSDirector/PDMR Shareholding
30th Jul 20207:00 amRNSTrading Update
24th Jul 20209:30 amRNSGrant of Options and PDMR Dealing
14th Jul 20204:21 pmRNSDirector/PDMR Shareholding
9th Jul 20204:40 pmRNSSecond Price Monitoring Extn
9th Jul 20204:35 pmRNSPrice Monitoring Extension
30th Jun 202012:27 pmRNSDirector/PDMR Shareholding
15th Jun 20205:35 pmRNSDirector/PDMR Shareholding
12th Jun 20201:30 pmRNSBlock listing Interim Review
2nd Jun 20203:37 pmRNSIssue of Equity and Total Voting Rights
1st Jun 20203:37 pmRNSDirector/PDMR Shareholding
29th May 20201:00 pmRNSTotal Voting Rights
26th May 20203:07 pmRNSResult of AGM
26th May 20207:00 amRNSAGM Statement
14th May 20204:49 pmRNSDirector/PDMR Shareholding
1st May 20206:18 pmRNSPosting of Report and Accounts and Notice of AGM
1st May 202011:58 amRNSHolding(s) in Company
30th Apr 20201:30 pmRNSTotal Voting Rights
30th Apr 202011:59 amRNSDirector/PDMR Shareholding
23rd Apr 20202:31 pmRNSDirector/PDMR Shareholding
23rd Apr 202011:46 amRNSDirector/PDMR Shareholding
23rd Apr 20207:00 amRNSFinal Results for the year ended 31 December 2019
14th Apr 20204:50 pmRNSDirector/PDMR Shareholding
8th Apr 20204:41 pmRNSSecond Price Monitoring Extn
8th Apr 20204:37 pmRNSPrice Monitoring Extension
31st Mar 202011:44 amRNSDirector/PDMR Shareholding
24th Mar 20207:00 amRNSFCA Moratorium on Publication of Results
23rd Mar 20204:41 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:38 pmRNSPrice Monitoring Extension
17th Mar 20203:50 pmRNSDirector/PDMR Shareholding
28th Feb 20202:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.